Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.

MLA

Wang, Eric, et al. “Mechanisms of Resistance to Noncovalent Bruton’s Tyrosine Kinase Inhibitors.” The New England Journal of Medicine, vol. 386, no. 8, Feb. 2022, pp. 735–43. EBSCOhost, https://doi.org/10.1056/NEJMoa2114110.

APA

Wang, E., Mi, X., Thompson, M. C., Montoya, S., Notti, R. Q., Afaghani, J., Durham, B. H., Penson, A., Witkowski, M. T., Lu, S. X., Bourcier, J., Hogg, S. J., Erickson, C., Cui, D., Cho, H., Singer, M., Totiger, T. M., Chaudhry, S., Geyer, M., … Abdel-Wahab, O. (2022). Mechanisms of Resistance to Noncovalent Bruton’s Tyrosine Kinase Inhibitors. The New England Journal of Medicine, 386(8), 735–743. https://doi.org/10.1056/NEJMoa2114110

Chicago

Wang, Eric, Xiaoli Mi, Meghan C Thompson, Skye Montoya, Ryan Q Notti, Jumana Afaghani, Benjamin H Durham, et al. 2022. “Mechanisms of Resistance to Noncovalent Bruton’s Tyrosine Kinase Inhibitors.” The New England Journal of Medicine 386 (8): 735–43. doi:10.1056/NEJMoa2114110.